<DOC>
	<DOCNO>NCT00471497</DOCNO>
	<brief_summary>In study , efficacy safety two nilotinib dos , 300 mg twice daily 400 mg twice daily , compare imatinib 400 mg daily newly diagnose patient Philadelphia chromosome-positive ( Ph+ ) Chronic Myelogenous Leukemia chronic phase ( CML-CP ) .</brief_summary>
	<brief_title>A Study Imatinib Versus Nilotinib Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive ( Ph+ ) Chronic Myelogenous Leukemia Chronic Phase ( CML-CP )</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Philadelphia Chromosome</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Inclusion criterion : Chronic myelogenous leukemia chronic phase patient within first 6 month diagnosis . Diagnosis chronic myelogenous leukemia chronic phase confirmation Philadelphia chromosome Exclusion criterion : Treatment tyrosine kinase inhibitor prior study entry allow except 2 week duration imatinib Any medical treatment CML prior study entry longer 2 week exception hydroxyurea and/or anagrelide Uncontrolled significant cardiovascular disease . Severe uncontrolled medical condition ( i.e . uncontrolled diabetes , active uncontrolled infection ) . Use therapeutic coumarin derivative ( i.e. , warfarin , acenocoumarol , phenprocoumon ) Currently take certain medication could affect rhythm heart . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>leukemia</keyword>
	<keyword>bone marrow</keyword>
	<keyword>leukemia symptom</keyword>
	<keyword>lukemia</keyword>
	<keyword>cml</keyword>
	<keyword>complete blood count</keyword>
	<keyword>lymphocyte</keyword>
	<keyword>blood cancer</keyword>
	<keyword>leukocyte</keyword>
	<keyword>chronic leukemia</keyword>
	<keyword>bone marrow biopsy</keyword>
	<keyword>leukemia research</keyword>
	<keyword>leukemia cell</keyword>
	<keyword>bone marrow disease</keyword>
	<keyword>chronic myeloid leukemia</keyword>
	<keyword>blood cancer symptom</keyword>
	<keyword>white blood cell disease</keyword>
	<keyword>chronic myelogenous leukemia</keyword>
	<keyword>leukemia treatment</keyword>
	<keyword>leukemia fact</keyword>
	<keyword>leucemia</keyword>
	<keyword>fact leukemia</keyword>
	<keyword>myelogenous leukemia</keyword>
	<keyword>newly diagnose CML</keyword>
	<keyword>newly diagnose Philadelphia chromosome positive ( Ph+ ) chronic myelogenous leukemia chronic phase ( CML-CP )</keyword>
</DOC>